相关实验视频

Updated: Feb 1, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Published on: October 5, 2012

针对BCL-XL降解的向与凝素对抗胆管癌的协同作用

Qinghua Zeng^1,2, Yan Zhang², Yiwen Yang³

¹Anhui Provincial Key Laboratory of Molecular Enzymology and Mechanism of Major Metabolic Diseases, College of Life Sciences, Anhui Normal University, Wuhu, Anhui, China.

|January 31, 2026

概括

胆管癌 (CCA) 的治疗耐药性可以通过使用BCL-XL特定的PROTACs来克服. 这种新的方法有效地向癌细胞,降低毒性并改善这种致命癌症的治疗结果.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
药物发现药物发现药物发现

背景情况:

胆管癌 (CCA) 是一种具有不良预后的致命癌症,通常是由于耐药性导致的.
抗亡的BCL-2蛋白 (BCL-XL,BCL-2,MCL-1) 的过度表达是抵抗的一个关键机制.
现有的BCL-XL抑制剂导致剂量限制性血液毒性,限制了临床使用.

研究的目的:

研究BCL-XL作为CCA中的治疗点.
在CCA中评估BCL-XL特异性蛋白质溶解向嵌合体 (PROTACs) 的疗效和安全性.
探索结合治疗和gemcitabine,以克服耐药性和最大限度地减少毒性.

主要方法:

在临床和临床前CCA模型中对BCL-2家族表达的综合分析.
利用蛋白质溶解向合体 (PROTAC) 技术开发BCL-XL特异性降解剂.
评估单疗法和组合治疗 in vitro 和 in vivo CCA 模型中的疗效.

主要成果:

确定BCL-XL是CCA治疗敏感性的关键因素.
与基于VHL的PROTAC (DT2216) 相比,基于CRBN的PROTAC XZ739在体外显示出更高的疗效,诱导了亡.
在体内,XZ739与凝胺结合,在CCA异种移植模型中抑制了瘤生长,没有显著的血小板狭窄.

结论:

XZ739是BCL-XL-依赖的CCA的一个有前途的治疗候选者.
PROTAC技术提供了一种策略,可以在CCA中准BCL-XL,同时减轻血液毒性.
理性结合XZ739和化疗具有克服CCA抵抗的翻译潜力.

关键词:

在BCL-XL之间.化疗化疗是一种化学疗法.胆性瘤是一种胆性瘤.这就是PROTAC.

更多相关视频

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on: July 14, 2022

Primer Extension Capture: Targeted Sequence Retrieval from Heavily Degraded DNA Sources

Primer Extension Capture: Targeted Sequence Retrieval from Heavily Degraded DNA Sources

Published on: September 3, 2009

相关概念视频

Regulated Protein Degradation

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

Regulated Protein Degradation

Regulated Protein Degradation

Proteins: From Genes to Degradation

Proteins: From Genes to Degradation

Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...

Proteins: From Genes to Degradation

Proteins: From Genes to Degradation

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Role of Matrix Metalloproteases in Degradation of ECM

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...